Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Ordinary Shares
-
Shares outstanding
-
130M
-
Number of holders
-
72
-
Total 13F shares, excl. options
-
50.9M
-
Shares change
-
+1.64M
-
Total reported value, excl. options
-
$86.1M
-
Value change
-
+$2.73M
-
Number of buys
-
41
-
Number of sells
-
-27
-
Price
-
$1.69
Significant Holders of PROKIDNEY CORP. - Ordinary Shares (PROK) as of Q4 2024
88 filings reported holding PROK - PROKIDNEY CORP. - Ordinary Shares as of Q4 2024.
PROKIDNEY CORP. - Ordinary Shares (PROK) has 72 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 50.9M shares
of 130M outstanding shares and own 39.22% of the company stock.
Largest 10 shareholders include MORGAN STANLEY (14M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (12.3M shares), BlackRock, Inc. (6.74M shares), VANGUARD GROUP INC (5.28M shares), GEODE CAPITAL MANAGEMENT, LLC (2.23M shares), Bleichroeder LP (2M shares), STATE STREET CORP (1.74M shares), Brown University (1M shares), NORTHERN TRUST CORP (891K shares), and CHARLES SCHWAB INVESTMENT MANAGEMENT INC (760K shares).
This table shows the top 72 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.